Bone mineral density is within normal range in most adult phenylketonuria patients
Charlotte M. A. Lubout(Emma Kinderziekenhuis), Annet M. Bosch(Emma Kinderziekenhuis), Francisco Arrieta(Hospital Universitario Ramón y Cajal), Francjan J. van Spronsen(University Medical Center Groningen), Carla E. M. Hollak(Centre For Development Studies), Margreet A. E. M. Wagenmakers(Erasmus MC), Katarzyna Bartosiewicz(Pomeranian Medical University), Mendy M. Welsink‐Karssies(Emma Kinderziekenhuis), F. Maillot(Université de Tours), François Feillet(Hôpital d'Enfants), Karolina M. Stępień(Salford Royal NHS Foundation Trust), Johanna H. van der Lee(Royal Dutch Pharmacists Association), Maria Giżewska(Pomeranian Medical University)
Cited by 36
Related Papers
The complete European guidelines on phenylketonuria: diagnosis and treatment
|Orphanet Journal of Rare Diseases|2017|814
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
|Proceedings of the National Academy of Sciences|2008|725
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study
|Journal of the American Society of Nephrology|2016|421
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
|Orphanet Journal of Rare Diseases|2015|345